Author

A. Vu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

M. D. Hogarty· 3 shared K. Liu· 2 shared Y. Li· 2 shared A. Wolpaw· 1 shared C. Burudpakdee· 1 shared C. Eigenmann· 1 shared C. P. Reynolds· 1 shared C. Turn· 1 shared

Activity by Year

2021-2024 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

M. D. Hogarty

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Reprogramming neuroblastoma by diet-enhanced polyamine depletion

S. Cherkaoui, L. Yang, M. J. McBride, C. Turn, W. Lu, C. Eigenmann, G. E. Allen, O. O. Panasenko, L. Zhang, A. Vu, K. Liu, Y. Li, O. H. Gandhi, L. Surrey, M. Wierer, , R. J. Morscher

This paper shows that combining dietary restriction of arginine and proline with polyamine depletion drugs enhances tumor differentiation and survival in a neuroblastoma mouse model by disrupting oncogenic translation.

bioRxiv · Jan 7, 2024Cancer Biology

The universal suppressor mutation in the HSV-1 nuclear egress complex restores membrane budding defects by stabilizing the oligomeric lattice

E. B. Draganova, H. Wang, M. Wu, S. Liao, A. Vu, G. Gonzalez-Del Pino, Z. H. Zhou, R. J. Roller, K. Heldwein

The study identifies a suppressor mutation in HSV-1 NEC that stabilizes the hexagonal lattice, restoring membrane budding in various mutants.

bioRxiv · Jun 22, 2023Biophysics

Anti-GD2 antibody therapy alters the neuroblastoma tumor microenvironment and extends survival in TH-MYCN mice

K. O. McNerney, S. Karageorgos, G. Ferry, A. Wolpaw, C. Burudpakdee, P. Khurana, R. Vemu, A. Vu, M. D. Hogarty, H. Bassiri

bioRxiv · Jun 9, 2021 · PreprintCancer Biology

Bexarotene derivatives modify responses in acute myeloid leukemia

G. Hadwiger, O. di Martino, M. A. Ferris, A. Vu, T. E. Frederick, G. R. Bowman, P. Ruminski, C. Wagner, J. S. Welch

This study screens bexarotene derivatives to identify compounds with enhanced anti-leukemic activity in AML, finding that dual RARA/RXRA activity and structural modifications affect potency and metabolic stability.

bioRxiv · May 17, 2021 · PreprintCancer Biology

REDUCED ER-MITOCHONDRIA CONNECTIVITY PROMOTES NEUROBLASTOMA MULTIDRUG RESISTANCE

J. Coku, D. M. Booth, J. Skoda, M. C. Pedrotty, J. Vogel, K. Liu, A. Vu, E. L. Carpenter, J. C. Ye, M. A. Chen, P. Dunbar, E. Scadden, E. Nakamaru-Ogiso, Y. Li, K. C. Goldsmith, , M. D. Hogarty

The paper identifies reduced ER-mitochondria contacts as a mechanism promoting neuroblastoma multidrug resistance by impairing Ca2+ transfer and apoptosis.

bioRxiv · Mar 1, 2021Cancer Biology